http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/05/wet-amd-avalanche-regeneron-regn-gene-therapy.html
Gene therapy company Avalanche Biotechnologies Inc. struck a deal potentially worth more than $640 million with Regeneron Pharmaceuticals Inc.
They are in PIIa.
Shows the potential deal BLT could get should their AMD program grow longer legs.